dc.contributor.author | DYKER, K. E. | |
dc.contributor.author | Oksuz, DİDEM | |
dc.contributor.author | FOSKER, C. | |
dc.contributor.author | COYLE, C. C. | |
dc.contributor.author | SEN, M. | |
dc.contributor.author | KANCHERLA, K. N. | |
dc.contributor.author | PRESTWICH, R. J. D. | |
dc.date.accessioned | 2021-03-04T07:57:28Z | |
dc.date.available | 2021-03-04T07:57:28Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | KANCHERLA K. N. , Oksuz D., PRESTWICH R. J. D. , FOSKER C., DYKER K. E. , COYLE C. C. , SEN M., "The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck Cancer", CLINICAL ONCOLOGY, cilt.23, sa.2, ss.141-148, 2011 | |
dc.identifier.issn | 0936-6555 | |
dc.identifier.other | av_60c39989-4ca3-4217-a507-e3a2f4777605 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/67507 | |
dc.identifier.uri | https://doi.org/10.1016/j.clon.2010.09.006 | |
dc.description.abstract | Aims: A significant proportion of patients with head and neck squamous cell carcinoma are unsuitable for radical treatment due to factors including tumour stage, performance status and co-morbidity. Palliative radiotherapy has a useful role in the control of local symptoms. This study documented the outcome with split-course hypofractionated radiotherapy. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck Cancer | |
dc.type | Makale | |
dc.relation.journal | CLINICAL ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 23 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 141 | |
dc.identifier.endpage | 148 | |
dc.contributor.firstauthorID | 72819 | |